23-valent pneumococcal polysaccharide vaccine (pneumovax-23) Report issue

Vaccine Approved FDA
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now
Pneumococcal polysaccharide vaccine (PPSV)—known as Pneumovax 23 (PPV-23)—is the first pneumococcal vaccine derived from a capsular polysaccharide.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

1,2,4-trichloro-5-((4-chlorophenyl)sulfinyl)benzene | 23-valent pneumococcal capsular polysaccharide vaccine | 23-valent pneumococcal polysaccharide vaccine | 23-valent ppv | 23-valent vaccine | 2,4,5,4'-tetrachlorodiphenylsulfoxide | pneumo23 | pneumo 23 | pneumo-23 | pneumococcal 23 valent polysaccharide vaccine | pneumococcal polysaccharide vaccine | pneumococcal vaccine, polyvalent | pneumococcal vaccine, polyvalent 23 | pneumovax | pneumovax 23 | pneumovax-23 | pneumovax ii | pnu-imune 23 | polysaccharide anti- pneumococcal vaccine | ppsv23 | ppv-23 | prodiax-23 | tetanus toxoid [tt]-containing adsorbed vaccine | v110

Organizations (126)

Research & Development (126)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (65)

Approved Indications (1)


 

Pneumococcal Vaccines (approved 1983)

Experimental Indications - Clinical Trial Phases 1-4 (65)


 

Aged (Phase 4)

Aging (Early Phase 1)

Anemia, Sickle Cell (Phase 2)

Arthritis, Juvenile (Phase 2/Phase 3)

Arthritis, Rheumatoid (Phase 4)

Asthma (Phase 4)

Axial Spondyloarthritis (Phase 4)

Bone Marrow Transplantation (Phase 4)

Breast Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 1)

Common Variable Immunodeficiency (Phase 2)

COVID-19 (Phase 4)

Crohn Disease (Phase 4)

Deficiency Diseases (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diphtheria (Phase 2)

Drugs, Investigational (Phase 2)

Haemophilus influenzae type b (Phase 2)

Healthy Volunteers (Phase 3)

Hematologic Diseases (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Herpes Zoster (Phase 3)

Herpes Zoster Vaccine (Phase 3)

HIV (Phase 4)

HIV-Associated Lipodystrophy Syndrome (Early Phase 1)

HIV Infections (Phase 4)

Immunization (Phase 2)

Infections (Phase 1/Phase 2)

Inflammatory Bowel Diseases (Phase 2)

Influenza, Human (Phase 4)

Kidney Failure, Chronic (Phase 4)

Kidney Transplantation (Phase 4)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)

Liver Transplantation (Phase 4)

Lung Diseases (Phase 4)

Lupus Erythematosus, Systemic (Phase 4)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 2)

Meningitis (Phase 2)

Meningococcal Infections (Phase 4)

Multiple Myeloma (Phase 2)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Pertussis Vaccine (Phase 2)

Pneumococcal Infections (Phase 4)

Pneumococcal Vaccines (Phase 3)

Pneumonia (Phase 4)

Pneumonia, Bacterial (Phase 1)

Pneumonia, Pneumococcal (Phase 4)

Pneumonia, Staphylococcal (Phase 4)

Poliomyelitis (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)

Psoriasis (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Sjogren's Syndrome (Phase 4)

Splenectomy (Phase 2)

Streptococcal Infections (Phase 3)

Streptococcus pneumoniae (Phase 3)

Systemic Vasculitis (Phase 4)

Tetanus (Phase 2)

Thalassemia (Phase 4)

Transplants (Phase 4)

Urinary Bladder Neoplasms (Phase 1)

Vaccination (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 158
  • # of Trial Organizations: 126

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue